Textbook of Pharmacovigilance by SK Gupta(Latest Edition)

Key Features of the Book:

1. Comprehensive Overview of Pharmacovigilance:
   • The book provides a thorough introduction to the concepts and principles of pharmacovigilance. It explains its importance in ensuring the safety of drugs post-marketing and focuses on monitoring and managing the adverse drug reactions (ADRs) that may occur after a drug has been introduced into the market.
   • It covers all aspects of pharmacovigilance, including regulatory requirements, global pharmacovigilance systems, risk management, and signal detection.
2. Structure and Content:
   • The book is systematically organized to provide a step-by-step approach to pharmacovigilance. Key chapters typically include:
     • Basic Concepts in Pharmacovigilance: An introduction to the field, key terms, and the importance of monitoring drug safety.
     • Adverse Drug Reactions (ADRs): In-depth coverage of various types of ADRs (type A, type B, and rare adverse events) and the methods of identifying and classifying them.
     • Pharmacovigilance Practices: Discussion of methods for detecting, evaluating, and reporting ADRs, including spontaneous reporting systems and databases.
     • Regulatory Framework: Overview of global pharmacovigilance regulations, including those from the World Health Organization (WHO), U.S. FDA, European Medicines Agency (EMA), and other regional regulatory bodies.
     • Post-Marketing Surveillance: Emphasizing the importance of monitoring drug safety after a product has been released to the market.
     • Risk Management and Risk Communication: Techniques for assessing the risks associated with medicines and communicating those risks to healthcare professionals and the public.
     • Signal Detection and Data Analysis: Advanced topics like statistical analysis in pharmacovigilance, signal detection methods, and use of databases like WHO-ART and MedDRA.
     • Pharmacovigilance in Special Populations: Consideration of how pharmacovigilance is managed for vulnerable populations such as children, elderly patients, and pregnant women.
3. Regulatory Guidelines and International Standards:
   • The book places a strong emphasis on global regulatory frameworks governing pharmacovigilance practices. It covers important international guidelines, including the ICH E2E pharmacovigilance guidelines, the Good Pharmacovigilance Practices (GVP) by the European Medicines Agency, and recommendations from the WHO and other national regulatory bodies.
   • It helps readers understand the role of different international organizations in drug safety surveillance and how they contribute to improving public health by ensuring that drugs are used safely.
4. Practical Application:
   • The book focuses on the practical aspects of pharmacovigilance, providing real-world examples and case studies to illustrate key concepts. These case studies highlight the detection, reporting, and management of ADRs in clinical practice and post-marketing surveillance.
   • Practical guidance is also given on how healthcare professionals, pharmaceutical companies, and regulatory agencies collaborate to detect adverse drug events and implement corrective actions if needed.
5. Clinical and Pharmacological Integration:
   • The textbook integrates pharmacology with clinical medicine, helping professionals in the field of pharmacy, medicine, and public health understand how pharmacovigilance fits into the broader context of patient care and drug therapy.
   • It explores the impact of pharmacovigilance on clinical decision-making, drug prescribing practices, and the role of healthcare providers in reporting ADRs.
6. Focus on ADR Reporting Systems:
   • A significant portion of the book is devoted to adverse drug reaction reporting systems, including how healthcare professionals can report adverse reactions through established national and international systems such as the VigiBase (WHO’s global ADR database).
   • It covers the importance of reporting ADRs in real-time, and the role of pharmacovigilance centers and drug safety monitoring organizations in analyzing these reports.
7. Emerging Trends in Pharmacovigilance:
   • The book addresses newer developments and trends in the field, such as the increasing use of big data, artificial intelligence (AI), and machine learning in pharmacovigilance to improve signal detection and the overall safety profile of drugs.
   • It also discusses the growing importance of social media and patient-reported outcomes in monitoring drug safety.
8. Glossary and Terminology:
   • A glossary of key terms and acronyms related to pharmacovigilance is included, which is particularly useful for beginners and professionals who are new to the field.

“Textbook of Pharmacovigilance” by SK Gupta is an essential reference for anyone involved in the study, practice, or regulation of pharmacovigilance. It provides a clear, comprehensive, and up-to-date overview of all aspects of drug safety, including regulatory frameworks, ADR monitoring, and risk management. Whether you’re a student, healthcare provider, or professional working in drug safety or regulatory affairs, this book offers valuable insights into how pharmacovigilance works to protect public health and improve patient care.